Literature DB >> 15328087

Penetration of Candida biofilms by antifungal agents.

Mohammed A Al-Fattani1, L Julia Douglas.   

Abstract

A filter disk assay was used to investigate the penetration of antifungal agents through biofilms containing single and mixed-species biofilms containing Candida. Fluconazole permeated all single-species Candida biofilms more rapidly than flucytosine. The rates of diffusion of either drug through biofilms of three strains of Candida albicans were similar. However, the rates of drug diffusion through biofilms of C. glabrata or C. krusei were faster than those through biofilms of C. parapsilosis or C. tropicalis. In all cases, after 3 to 6 h the drug concentration at the distal edge of the biofilm was very high (many times the MIC). Nevertheless, drug penetration failed to produce complete killing of biofilm cells. These results indicate that poor antifungal penetration is not a major drug resistance mechanism for Candida biofilms. The abilities of flucytosine, fluconazole, amphotericin B, and voriconazole to penetrate mixed-species biofilms containing C. albicans and Staphylococcus epidermidis (a slime-producing wild-type strain, RP62A, and a slime-negative mutant, M7) were also investigated. All four antifungal agents diffused very slowly through these mixed-species biofilms. In most cases, diffusion was slower with biofilms containing S. epidermidis RP62A, but amphotericin B penetrated biofilms containing the M7 mutant more slowly. However, the drug concentrations reaching the distal edges of the biofilms always substantially exceeded the MIC. Thus, although the presence of bacteria and bacterial matrix material undoubtedly retarded the diffusion of the antifungal agents, poor penetration does not account for the drug resistance of Candida biofilm cells, even in these mixed-species biofilms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328087      PMCID: PMC514766          DOI: 10.1128/AAC.48.9.3291-3297.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  42 in total

1.  Antifungal resistance of candidal biofilms formed on denture acrylic in vitro.

Authors:  J Chandra; P K Mukherjee; S D Leidich; F F Faddoul; L L Hoyer; L J Douglas; M A Ghannoum
Journal:  J Dent Res       Date:  2001-03       Impact factor: 6.116

Review 2.  The physiology and collective recalcitrance of microbial biofilm communities.

Authors:  Peter Gilbert; Tomas Maira-Litran; Andrew J McBain; Alexander H Rickard; Fraser W Whyte
Journal:  Adv Microb Physiol       Date:  2002       Impact factor: 3.517

3.  Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms.

Authors:  Gordon Ramage; Stefano Bachmann; Thomas F Patterson; Brian L Wickes; José L López-Ribot
Journal:  J Antimicrob Chemother       Date:  2002-06       Impact factor: 5.790

4.  Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection.

Authors:  Russell E Lewis; Dimitrios P Kontoyiannis; Rabih O Darouiche; Issam I Raad; Randall A Prince
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

5.  In vitro activity of caspofungin against Candida albicans biofilms.

Authors:  Stefano P Bachmann; Kacy VandeWalle; Gordon Ramage; Thomas F Patterson; Brian L Wickes; John R Graybill; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

6.  Biofilm formation by Candida dubliniensis.

Authors:  G Ramage; K Vande Walle; B L Wickes; J L López-Ribot
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

7.  Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.

Authors:  G Ramage; K Vande Walle; B L Wickes; J L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

8.  Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

Authors:  D M Kuhn; T George; J Chandra; P K Mukherjee; M A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

9.  Mixed species biofilms of Candida albicans and Staphylococcus epidermidis.

Authors:  Berit Adam; George S Baillie; L Julia Douglas
Journal:  J Med Microbiol       Date:  2002-04       Impact factor: 2.472

Review 10.  Biofilms: survival mechanisms of clinically relevant microorganisms.

Authors:  Rodney M Donlan; J William Costerton
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

View more
  65 in total

Review 1.  Bacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologists.

Authors:  P Frey-Klett; P Burlinson; A Deveau; M Barret; M Tarkka; A Sarniguet
Journal:  Microbiol Mol Biol Rev       Date:  2011-12       Impact factor: 11.056

Review 2.  Candida biofilms: an update.

Authors:  Gordon Ramage; Stephen P Saville; Derek P Thomas; José L López-Ribot
Journal:  Eukaryot Cell       Date:  2005-04

3.  Protein O-mannosyltransferase isoforms regulate biofilm formation in Candida albicans.

Authors:  Heidrun Peltroche-Llacsahuanga; Sophie Goyard; Christophe d'Enfert; Stephan K-H Prill; Joachim F Ernst
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

4.  Antibody-guided alpha radiation effectively damages fungal biofilms.

Authors:  L R Martinez; R A Bryan; C Apostolidis; A Morgenstern; A Casadevall; E Dadachova
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

5.  Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms.

Authors:  M Guembe; J Guinea; L J Marcos-Zambrano; A Fernández-Cruz; T Peláez; P Muñoz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

6.  Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance.

Authors:  Melphine M Harriott; Mairi C Noverr
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

7.  Candida bracarensis: Evaluation of Virulence Factors and its Tolerance to Amphotericin B and Fluconazole.

Authors:  André Moreira; Sónia Silva; Cláudia Botelho; Paula Sampaio; Célia Pais; Mariana Henriques
Journal:  Mycopathologia       Date:  2015-07-16       Impact factor: 2.574

8.  In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species.

Authors:  Barbara Fiori; Brunella Posteraro; Riccardo Torelli; Mario Tumbarello; David S Perlin; Giovanni Fadda; Maurizio Sanguinetti
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

9.  The Effectiveness of Voriconazole in Therapy of Candida glabrata's Biofilms Oral Infections and Its Influence on the Matrix Composition and Gene Expression.

Authors:  Célia F Rodrigues; Bruna Gonçalves; Maria Elisa Rodrigues; Sónia Silva; Joana Azeredo; Mariana Henriques
Journal:  Mycopathologia       Date:  2017-04-24       Impact factor: 2.574

10.  Absence of amphotericin B-tolerant persister cells in biofilms of some Candida species.

Authors:  Rawya S Al-Dhaheri; L Julia Douglas
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.